相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
Ibai Goicoechea et al.
BLOOD (2021)
Treatment of therapy-related acute myeloid leukemia and underlying multiple myeloma with decitabine/venetoclax and daratumumab
Khalid Shoumariyeh et al.
ANNALS OF HEMATOLOGY (2021)
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
Stefania Oliva et al.
FRONTIERS IN ONCOLOGY (2020)
Risk of disease recurrence and survival in patients with multiple myeloma: A German study group analysis using a conditional survival approach with long-term follow-up of 815 patients
Maximilian Schinke et al.
CANCER (2020)
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myeloma
Sandra Maria Dold et al.
HAEMATOLOGICA (2020)
Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis
Ioannis Ntanasis-Stathopoulos et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
The Impact of Tumor Heterogeneity on Diagnostics and Novel Therapeutic Strategies in Multiple Myeloma
Leo Rasche et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
What to do with minimal residual disease testing in myeloma
Elisabet E. Manasanch
Hematology-American Society of Hematology Education Program (2019)
Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials
P. Arana et al.
LEUKEMIA (2018)
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
J. Flores-Montero et al.
LEUKEMIA (2017)
Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma A Meta-analysis
Nikhil C. Munshi et al.
JAMA ONCOLOGY (2017)
Single-Tube 10-Fluorochrome Analysis for Efficient Flow Cytometric Evaluation of Minimal Residual Disease in Plasma Cell Myeloma
Daniel J. Royston et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Assessment of tumoral plasma cells in apheresis products for autologous stem cell transplantation in multiple myeloma
S. Wuilleme et al.
BONE MARROW TRANSPLANTATION (2016)
Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction
Andy C. Rawstron et al.
BLOOD (2015)
Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma
Daisy Alapat et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma
H. G. Kopp et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
Andy C. Rawstron et al.
HAEMATOLOGICA (2008)
CD200 is a new prognostic factor in multiple myeloma
Jerome Moreaux et al.
BLOOD (2006)
分享论文
